0001214659-18-000291.txt : 20180109
0001214659-18-000291.hdr.sgml : 20180109
20180109063457
ACCESSION NUMBER: 0001214659-18-000291
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180105
FILED AS OF DATE: 20180109
DATE AS OF CHANGE: 20180109
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Thompson David E.
CENTRAL INDEX KEY: 0001484500
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34637
FILM NUMBER: 18517825
MAIL ADDRESS:
STREET 1: C/O ANTHERA PHARMACEUTICALS, INC.
STREET 2: 25801 INDUSTRIAL BOULEVARD, SUITE B
CITY: HAYWARD
STATE: CA
ZIP: 94545
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Anthera Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001316175
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 201852016
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 25801 INDUSTRIAL BOULEVARD, SUITE B
CITY: HAYWARD
STATE: CA
ZIP: 94545
BUSINESS PHONE: (510) 856-5600
MAIL ADDRESS:
STREET 1: 25801 INDUSTRIAL BOULEVARD, SUITE B
CITY: HAYWARD
STATE: CA
ZIP: 94545
4
1
marketforms-40679.xml
PRIMARY DOCUMENT
X0306
4
2018-01-05
0001316175
Anthera Pharmaceuticals Inc
ANTH
0001484500
Thompson David E.
25801 INDUSTRIAL BLVD SUITE B
HAYWARD
CA
94545
true
false
false
false
Stock Option (right to buy)
1.65
2018-01-05
4
A
false
84705
0
A
2028-01-05
Common Stock
84705
84705
D
Stock Option (right to buy)
1.65
2018-01-05
4
A
false
84705
0
A
2028-01-05
Common Stock
84705
84705
D
This option is granted pursuant to the Company's director compensation program and is for fiscal year ending December 31, 2017. This option vests in 12 equal monthly installments. The vesting commencement date is April 27, 2017.
This option is granted pursuant to the Company's director compensation program and is for fiscal year ending December 31, 2018. This option vests in 12 equal monthly installments. The vesting commencement date is commensurate with the grant date of January 5, 2018.
/s/ May Liu by power of attorney
2018-01-09